Glycogen storage disease type I physical examination: Difference between revisions
No edit summary |
|||
| Line 7: | Line 7: | ||
==Physical Exmaination== | ==Physical Exmaination== | ||
Physical examination of patients with glycogen storage disease type 1 is usually remarkable for protruding [[abdomen]] due to marked [[hepatomegaly]], [[short stature]], doll-like facial appearance, truncal obesity, and wasted [[muscles]].<ref name="pmid17552001">{{cite journal| author=Ozen H| title=Glycogen storage diseases: new perspectives. | journal=World J Gastroenterol | year= 2007 | volume= 13 | issue= 18 | pages= 2541-53 | pmid=17552001 | doi= | pmc=4146814 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17552001 }} </ref> | Physical examination of patients with glycogen storage disease type 1 is usually remarkable for protruding [[abdomen]] due to marked [[hepatomegaly]], [[short stature]], doll-like facial appearance, truncal obesity, and wasted [[muscles]].<ref name="pmid17552001">{{cite journal| author=Ozen H| title=Glycogen storage diseases: new perspectives. | journal=World J Gastroenterol | year= 2007 | volume= 13 | issue= 18 | pages= 2541-53 | pmid=17552001 | doi= | pmc=4146814 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17552001 }} </ref><ref name="pmid13029898">{{cite journal| author=ZAKON SJ, OYAMADA A, ROSENTHAL IH| title=Eruptive xanthoma and hyperlipemia in glycogen storage disease (von Gierke's disease). | journal=AMA Arch Derm Syphilol | year= 1953 | volume= 67 | issue= 2 | pages= 146-51 | pmid=13029898 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13029898 }} </ref> | ||
===Appearance of the Patient=== | ===Appearance of the Patient=== | ||
Revision as of 21:38, 27 November 2017
|
Glycogen storage disease type I Microchapters |
|
Differentiating Glycogen storage disease type I from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glycogen storage disease type I physical examination On the Web |
|
American Roentgen Ray Society Images of Glycogen storage disease type I physical examination |
|
Glycogen storage disease type I physical examination in the news |
|
Blogs on Glycogen storage disease type I physical examination |
|
Directions to Hospitals Treating Glycogen storage disease type I |
|
Risk calculators and risk factors for Glycogen storage disease type I physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
Physical examination of patients with glycogen storage disease type 1 is usually remarkable for protruding abdomen due to marked hepatomegaly, short stature, doll-like facial appearance, truncal obesity, and wasted muscles.
Physical Exmaination
Physical examination of patients with glycogen storage disease type 1 is usually remarkable for protruding abdomen due to marked hepatomegaly, short stature, doll-like facial appearance, truncal obesity, and wasted muscles.[1][2]
Appearance of the Patient
- Patients with glycogen storage disease type 1 usually have a doll-like facial appearance caused by adipose tissue deposition in the cheeks.
Skin
Signs due to hypoglycemia include:
HEENT
Lungs
Signs due to hypoglycemia include:
Abdomen
- Protruding abdomen due to marked hepatomegaly (storage of glycogen and fat)
Neuromuscular
Signs due to hypoglycemia in infants include:
Older infants show signs including:
Extremities
- Cyanosis
- Growth retardation
- Relatively thin extremities
- Xanthoma may be found on extensor surfaces, such as the elbows and knees
References
- ↑ Ozen H (2007). "Glycogen storage diseases: new perspectives". World J Gastroenterol. 13 (18): 2541–53. PMC 4146814. PMID 17552001.
- ↑ ZAKON SJ, OYAMADA A, ROSENTHAL IH (1953). "Eruptive xanthoma and hyperlipemia in glycogen storage disease (von Gierke's disease)". AMA Arch Derm Syphilol. 67 (2): 146–51. PMID 13029898.